Literature DB >> 10552150

Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification: a review.

A Hesse1, D Heimbach.   

Abstract

The most important phosphates involved in urinary stone disease are carbonate apatite, brushite, and struvite. Overall, phosphate stones account for 12-20% of all stones, with a downward trend for struvite and an increase in carbonate apatite being observed in the last decade. The physicochemical basis for the formation of phosphate calculi is supersaturation. Once the solubility product has been exceeded, a metastable process of supersaturation begins, with slow crystalline growth. If a critical limit of supersaturation is exceeded, large-scale spontaneous precipitation of crystals occurs in a second stage. No urinary tract infection is involved in brushite stone formation. Although infection is not a prerequisite for the formation of carbonate apatite stones, infective conditions favor carbonate apatite formation. Struvite is the characteristic infection calculus, formed as a result of urinary tract infection with urease-producing bacteria. During the first episode of urinary stone disease a definitive diagnosis of the type of stone involved is very difficult without analysis of the latter by infrared spectroscopy or X-ray diffraction. In recurrent disease, appropriate treatment can be initiated on the basis of the previous stone analysis in the majority of cases. The best means of preventing recurrent disease involving any type of phosphate stone is definitive calculus removal by shock-wave lithotripsy, percutaneous stone removal, or open surgery (especially in children). Chemolysis via acidification of the urine with Suby G solution or hemicidrin supported by oral acidification, achieved by the metabolism of L-methionine, and antibiotic therapy (especially for infectious stones) are important adjuvant modalities of therapy. After therapy of phosphate stones, metaphylaxis involving controlled urinary acidification with L-methionine supports the treatment of infection and, at a pH value of less than 6.2 and urine dilution to 2.5 l/24 h, prevents the crystallization of struvite, brushite, and carbonate apatite.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10552150     DOI: 10.1007/s003450050152

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  31 in total

1.  The effect of dietary factors on the risk of developing urinary tract infection.

Authors:  H Kalhoff
Journal:  Pediatr Nephrol       Date:  2004-08-20       Impact factor: 3.714

2.  Analysis of mixed stones is prone to error: a study with US laboratories using micro CT for verification of sample content.

Authors:  Amy E Krambeck; James E Lingeman; James A McAteer; James C Williams
Journal:  Urol Res       Date:  2010-10-22

Review 3.  [Evidence-based pharmacological metaphylaxis of stone disease].

Authors:  M Straub; R E Hautmann
Journal:  Urologe A       Date:  2006-11       Impact factor: 0.639

4.  High carbonate level of apatite in kidney stones implies infection, but is it predictive?

Authors:  Kate M Englert; James A McAteer; James E Lingeman; James C Williams
Journal:  Urolithiasis       Date:  2013-07-24       Impact factor: 3.436

5.  Growth inhibition of Struvite crystals in the presence of juice of Citrus medica Linn.

Authors:  C K Chauhan; M J Joshi
Journal:  Urol Res       Date:  2008-09-16

6.  Should metabolic evaluation be performed in patients with struvite stones?

Authors:  Muhammad Waqas Iqbal; Richard H Shin; Ramy F Youssef; Adam G Kaplan; Fernando J Cabrera; Jonathan Hanna; Charles D Scales; Michael N Ferrandino; Glenn M Preminger; Michael E Lipkin
Journal:  Urolithiasis       Date:  2016-05-30       Impact factor: 3.436

Review 7.  [Recurrence prevention of kidney stone disease].

Authors:  M Straub
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

8.  Stability of the infection marker struvite in urinary stone samples.

Authors:  James C Williams; Andrew J Sacks; Kate Englert; Rachel Deal; Takeisha L Farmer; Molly E Jackson; James E Lingeman; James A McAteer
Journal:  J Endourol       Date:  2011-10-11       Impact factor: 2.942

9.  Supersaturation of body fluids, plasma and urine, with respect to biological hydroxyapatite.

Authors:  Otakar Söhnel; Felix Grases
Journal:  Urol Res       Date:  2011-05-14

10.  Growth inhibition of struvite crystals in the presence of herbal extract Commiphora wightii.

Authors:  C K Chauhan; M J Joshi; A D B Vaidya
Journal:  J Mater Sci Mater Med       Date:  2008-06-21       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.